Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ)
CNY 15.7
(2.61%)
CNY 15.7
(2.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 664.07 Million | 255.62 Million | 437.18 Million | 546.12 Million | 577.98 Million | 352.19 Million |
| Net Income | 193.31 Million | 285.87 Million | 123.08 Million | -480.67 Million | 214 Million | 282.31 Million |
| Depreciation & Amortization | 308.17 Million | 255.76 Million | 224.02 Million | 198.04 Million | 179.16 Million | 169.42 Million |
| Deferred income taxes | -21.41 Million | 12.29 Million | 24.02 Million | -10.31 Million | 12.52 Million | -11.4 Million |
| Stock-based compensation | -16.46 Million | 16.46 Million | - | - | - | - |
| Change in working capital | 99.3 Million | -377.16 Million | -3.72 Million | 10.9 Million | 16.13 Million | -288.12 Million |
| Other non-cash items | 63.28 Million | 91.14 Million | 93.79 Million | 817.85 Million | 168.67 Million | 188.58 Million |
| Investing Cash Flow | -309.98 Million | -357.82 Million | -231.54 Million | -450.94 Million | -93.44 Million | -409.17 Million |
| Investments in PPE | -342.89 Million | -373.66 Million | -376.14 Million | -272.43 Million | -361.65 Million | -349.88 Million |
| Acquisitions | 24.85 Million | 6.47 Million | 6.2 Million | 2.86 Million | 23.96 Million | -5.07 Million |
| Investment purchases | -5 Million | -15 Million | -7.8 Million | -181.4 Million | -25.69 Million | -55 Million |
| Sales/Maturities of investments | 2.29 Million | 4.8 Million | 150.4 Million | 500 Thousand | 44.05 Million | 2.89 Million |
| Other Investing Activities | 10.76 Million | 19.56 Million | -4.2 Million | -479.99 Thousand | 225.88 Million | -2.1 Million |
| Financing Cash Flow | -243.31 Million | 3.82 Million | -191.66 Million | -192.48 Million | -220.55 Million | 86.32 Million |
| Debt repayment | -446.2 Million | -414.84 Million | -385.11 Million | -463.9 Million | -396.6 Million | -292.6 Million |
| Dividends payments | -57.17 Million | -76.47 Million | -77.48 Million | -77.73 Million | -97.56 Million | -94.73 Million |
| Common Stock Repurchased | - | -56.93 Million | -80 Million | -59.58 Million | -4.94 Million | -40 Million |
| Common Stock Issuance | - | 56.93 Million | 80 Million | 59.58 Million | 4.94 Million | - |
| Other Financing Activities | 286.41 Million | 523.44 Million | 298.65 Million | 372.28 Million | 298.62 Million | 473.66 Million |
| Accounts receivables | -124.9 Million | -314.19 Million | -89.09 Million | -22.34 Million | -88.63 Million | -218.94 Million |
| Accounts payables | 213.54 Million | 127.52 Million | 194.71 Million | 84.19 Million | 58.86 Million | -6.01 Million |
| Inventory | 32.08 Million | -202.77 Million | -133.36 Million | -40.63 Million | 33.38 Million | -51.75 Million |
| Other working capital | -21.41 Million | 12.29 Million | 24.02 Million | -10.31 Million | 12.52 Million | -236.36 Million |
| Cash at beginning of period | 789.77 Million | 883.84 Million | 874.83 Million | 977.2 Million | 712.22 Million | 682.92 Million |
| Cash at end of period | 904.02 Million | 789.77 Million | 883.84 Million | 874.83 Million | 977.2 Million | 712.22 Million |
| Capital Expenditure | -342.89 Million | -373.66 Million | -376.14 Million | -272.43 Million | -361.65 Million | -349.88 Million |
| Effect of forex changes on cash | 3.46 Million | 4.29 Million | -4.97 Million | -5.06 Million | 999.74 Thousand | -61.53 Thousand |
| Net cash flow / Change in cash | 114.24 Million | -94.06 Million | 9.01 Million | -102.37 Million | 264.98 Million | 29.29 Million |
| Free Cash Flow | 321.17 Million | -118.04 Million | 61.04 Million | 273.69 Million | 216.33 Million | 2.31 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.46 Million | 47.62 Million | 82.97 Million | 42.22 Million | 193.31 Million | 30.77 Million |
| Depreciation & Amortization | - | 81.46 Million | 81.46 Million | 79.02 Million | 308.17 Million | 79.02 Million |
| Deferred income taxes | - | - | - | 125.74 Million | -21.41 Million | 20.28 Million |
| Stock-based compensation | - | - | - | -16.46 Million | -16.46 Million | -10.94 Million |
| Change in working capital | - | 55.82 Million | - | -109.28 Million | 99.3 Million | -9.34 Million |
| Other non-cash items | 6.02 Million | 167.42 Million | -41.59 Million | 207.64 Million | 63.28 Million | 91.01 Million |
| Investing Cash Flow | -83.17 Million | 30.21 Million | -50.41 Million | -152.62 Million | -309.98 Million | -28.03 Million |
| Investments in PPE | -33.51 Million | -30.3 Million | -48.2 Million | -150.47 Million | -342.89 Million | -51.24 Million |
| Acquisitions | 1.11 Million | 59.22 Million | 1.53 Million | -4.02 Million | 24.85 Million | 22.85 Million |
| Investment purchases | 108 Million | -109 Million | -3 Million | -149.23 Million | -5 Million | 64.23 Million |
| Sales/Maturities of investments | -109.56 Million | 109.56 Million | - | 1.3 Million | 2.29 Million | -87.08 Million |
| Other Investing Activities | -49.65 Million | 744.21 Thousand | -744.21 Thousand | 149.8 Million | 10.76 Million | 23.2 Million |
| Financing Cash Flow | -65.8 Million | -118.1 Million | 24.75 Million | -149.97 Million | -243.31 Million | -570.14 Thousand |
| Debt repayment | -7.67 Million | -36.72 Million | -85.81 Million | -131.3 Million | -446.2 Million | -102.29 Million |
| Dividends payments | -42.46 Million | -80.63 Million | -5.01 Million | -57.17 Million | -57.17 Million | -6.07 Million |
| Common Stock Repurchased | 55 Million | -55 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -15.66 Million | 51.27 Million | -61.06 Million | -12.49 Million | 286.41 Million | 107.8 Million |
| Accounts receivables | - | 97.17 Million | - | -124.9 Million | -124.9 Million | 22.06 Million |
| Accounts payables | - | - | - | - | 213.54 Million | - |
| Inventory | - | -41.34 Million | - | 32.08 Million | 32.08 Million | -20.46 Million |
| Other working capital | - | - | - | -16.46 Million | -21.41 Million | -10.94 Million |
| Cash at beginning of period | 969.3 Million | 1.05 Billion | 1.02 Billion | 1 Billion | 789.77 Million | 850.4 Million |
| Cash at end of period | 847.17 Million | 1.07 Billion | 1.05 Billion | 904.02 Million | 904.02 Million | 1 Billion |
| Capital Expenditure | -33.51 Million | -30.3 Million | -48.2 Million | -150.47 Million | -342.89 Million | -51.24 Million |
| Effect of forex changes on cash | 357.09 Thousand | 2.61 Million | 1.27 Million | 963.26 Thousand | 3.46 Million | 1.16 Million |
| Net cash flow / Change in cash | -122.13 Million | 19.53 Million | 30 Million | -98.47 Million | 114.24 Million | 152.08 Million |
| Free Cash Flow | -7.03 Million | 103.26 Million | -6.83 Million | 52.68 Million | 321.17 Million | 129.27 Million |
CCOEY
TDS
TIAIY
GLRI
910322
MLPT